Sources | Names Used |
---|---|
CTRPv2 | tretinoin:navitoclax (4:1 mol/mol) |
PharmacoGx | tretinoin:navitoclax (4:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | HACD4 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | C6orf120 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | PSMD7 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | ZNF66 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | C1orf168 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | ABCE1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | SYT2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | PCDHA1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | B4GALNT4 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | PPCDC | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |